New horizons for sedation: The ultrashort acting benzodiazepine remimazolam

Procedural sedation is used in 98% of endoscopies performed in the United States. The predominant agents used are benzodiazepines, opioids, and propofol. The optimal sedation depends on the procedure being performed and its duration. An ideal sedative would allow for flexible, rapid onset and offset of sedation with predictable short duration of action with minimal cardiopulmonary risk factors. Remimazolam is a novel “soft drug” with the characteristics of a benzodiazepine and organ-independent metabolism.
Source: Techniques in Gastrointestinal Endoscopy - Category: Gastroenterology Authors: Source Type: research